Latest Breaking News On - Sanjk patel - Page 1 : vimarsana.com

Wells Fargo & Company Begins Coverage on Kiniksa Pharmaceuticals (NASDAQ:KNSA)

Wells Fargo & Company Begins Coverage on Kiniksa Pharmaceuticals (NASDAQ:KNSA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sanjk patelKiniksa pharmaceuticalsAltitude crest partners incJpmorgan chase coKiniksa pharmaceuticals ltdPeregrine capital managementParkman healthcare partnersKiniksa pharmaceuticals stock downConnor clark lunn investment management ltdWells fargo companyGranahan investment managementNews ratings for kiniksa pharmaceuticals dailyKiniksa pharmaceuticals company profileInsider transactions at kiniksa pharmaceuticalsWells fargoFree report

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30 00 at JPMorgan Chase & Co

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30 00 at JPMorgan Chase & Co
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Michaelr megnaSanjk patelVictory capital management incSg americas securitiesHedge funds weigh in on kiniksa pharmaceuticalsNews ratings for kiniksa pharmaceuticals dailyKiniksa pharmaceuticals company profileInsider activity at kiniksa pharmaceuticalsCapital management incJpmorgan chase coKiniksa pharmaceuticalsDynamic technology lab private ltdKiniksa pharmaceuticals tradingKiniksa pharmaceuticals ltdChina universal asset management coFree report

Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA) Forecasted to Post Q2 2024 Earnings of ($0 06) Per Share

Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA) Forecasted to Post Q2 2024 Earnings of ($0 06) Per Share
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sanjk patelMichaelr megnaNews ratings for kiniksa pharmaceuticals dailyKiniksa pharmaceuticals company profileKiniksa pharmaceuticals ltdGranahan investment managementInstitutional trading of kiniksa pharmaceuticalsParkman healthcare partnersOpaleye management incAllspring global investments holdingsHennion walsh asset management incKiniksa pharmaceuticalsKiniksa pharmaceuticals price performanceSecurities exchange commissionFree reportKiniksa pharmaceutical

Evercore ISI Increases Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30 00

Evercore ISI Increases Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target to $30 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Michaelr megnaSanjk patelPrincipal financial group incInsider transactions at kiniksa pharmaceuticalsSecurities exchange commissionLinden thomas advisory servicesChina universal asset management coConnor clark lunn investment management ltdKiniksa pharmaceuticals stock performanceKiniksa pharmaceuticals ltdAlps advisors incInstitutional investors weigh in on kiniksa pharmaceuticalsNews ratings for kiniksa pharmaceuticals dailyKiniksa pharmaceuticalsGet free reportExchange commission

Linden Thomas Advisory Services LLC Has $2 01 Million Holdings in Kiniksa Pharmaceuticals, Ltd (NASDAQ:KNSA)

Linden Thomas Advisory Services LLC cut its position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) by 1.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 114,550 shares of the company’s stock after selling 1,341 shares during the quarter. Linden Thomas Advisory Services LLC’s holdings in Kiniksa Pharmaceuticals were worth $2,009,000 as of […]

Sanjk patelNews ratings for kiniksa pharmaceuticals dailyAcadian asset managementConnor clark lunn investment management ltdSchonfeld strategic advisorsQuarter for kiniksa pharmaceuticalsKiniksa pharmaceuticals company profileKiniksa pharmaceuticals stockLinden thomas advisory servicesSecurities exchange commissionInsider transactions at kiniksa pharmaceuticalsKiniksa pharmaceuticals ltdExchange commissionYork mellon corpKiniksa pharmaceuticalsBarclays plc